Company Filing History:
Years Active: 2012
Title: Gary Rogers: Innovator in Neuropharmacology
Introduction
Gary Rogers is a notable inventor based in Basseterre, Saint Kitts and Nevis. He has made significant contributions to the field of neuropharmacology, particularly in the development of compounds aimed at enhancing cognitive functions.
Latest Patents
Gary Rogers holds a patent for a 3-substituted-[1,2,3]-benzotriazinone compound. This invention is designed for the prevention and treatment of cerebral insufficiency. It focuses on enhancing receptor functioning in synapses within brain networks that are responsible for higher-order behaviors. The compound addresses cognitive abilities related to memory impairment, which can be observed in various forms of dementia. Additionally, it aims to correct imbalances in neuronal activity between different brain regions, which is suggested in disorders such as Parkinson's disease, schizophrenia, and affective disorders.
Career Highlights
Gary Rogers is associated with Les Laboratoires Servier, where he applies his expertise in neuropharmacology. His work has the potential to impact the treatment of cognitive disorders significantly.
Collaborations
Gary collaborates with talented individuals such as Alexis Cordi and Rudolf Mueller, contributing to advancements in their field.
Conclusion
Gary Rogers is a pioneering inventor whose work in neuropharmacology holds promise for improving cognitive health. His innovative approaches to treating cerebral insufficiency and related disorders are noteworthy contributions to medical science.